25-Apr-2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FFNW, MGRC, CTLT, HRT
PRNewswire (Tue, 23-Apr 1:04 PM ET)
Goldman’s debt issuers stocks basket
Seeking Alpha News (Mon, 22-Apr 12:53 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, CHRD
Globe Newswire (Sat, 20-Apr 11:18 AM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SCX
PRNewswire (Thu, 18-Apr 12:20 PM ET)
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)
Business Wire (Wed, 17-Apr 8:19 PM ET)
PRNewswire (Wed, 17-Apr 7:45 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA
PRNewswire (Thu, 11-Apr 1:00 PM ET)
Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
Globe Newswire (Wed, 10-Apr 11:03 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, SCX, EVBG, NS
Globe Newswire (Thu, 4-Apr 11:16 AM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI
PRNewswire (Fri, 22-Mar 6:59 PM ET)
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Catalent trades on the NYSE stock market under the symbol CTLT.
As of April 25, 2024, CTLT stock price declined to $55.80 with 1,606,435 million shares trading.
CTLT has a beta of 1.60, meaning it tends to be more sensitive to market movements. CTLT has a correlation of 0.12 to the broad based SPY ETF.
CTLT has a market cap of $10.10 billion. This is considered a Large Cap stock.
Last quarter Catalent reported $1 billion in Revenue and -$.24 earnings per share. This beat revenue expectation by $22 million and missed earnings estimates by -$.22.
In the last 3 years, CTLT stock traded as high as $142.64 and as low as $31.45.
The top ETF exchange traded funds that CTLT belongs to (by Net Assets): VTI, VOO, VB, SPY, RSP.
CTLT has outperformed the market in the last year with a price return of +31.7% while the SPY ETF gained +25.6%. CTLT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.7% and -2.0%, respectively, while the SPY returned +3.5% and -2.8%, respectively.
CTLT support price is $55.59 and resistance is $56.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTLT stock will trade within this expected range on the day.